About

From the lab bench to the market.

Nice to meet you, and welcome. I'm Michelle. As a molecular biologist with a PhD, I have dedicated my scientific knowledge and experience to commercial leadership, particularly in molecular diagnostics. At this stage of my career, I find it most meaningful to help life sciences and diagnostics companies turn great science into real-world adoption.

Portrait of Dr. Michelle Meijer

My story

Where science meets the market

I have always been fascinated by what happens when science leaves the lab.

After an MSc in biology at Leiden University and a PhD in molecular biology at Utrecht University, in collaboration with Unilever Research, I chose to work where innovation meets the market. For more than 25 years I have introduced and grown molecular diagnostics in the Netherlands, the Benelux and internationally.

From PCR and next-generation sequencing at Westburg, to pioneering HPV DNA testing at Roche Diagnostics. From building QIAGEN's Benelux business across infectious diseases, HPV and personalised healthcare, to leading commercial teams at OncoDNA, ENPICOM and Self-screen, where I helped scale molecular triage assays for cervical cancer screening. Along the way I trained in Miller Heiman Strategic Selling, co-trained its programmes, and received several sales leadership awards.

Every new technology is a new adventure: a market to understand, different stakeholders to convince, a path to adoption to discover.

Through InFacts I share that experience as a consultant, interim leader and trainer, with companies that want their innovation to make a difference in practice.

Where my heart is

Molecular diagnostics, cervical cancer prevention and women's health

My home base is molecular diagnostics. My deepest knowledge, experience and network lie in HPV diagnostics and cervical cancer prevention, and that is also where my greatest passion lies: contributing to the elimination of cervical cancer.

Looking ahead, I see enormous potential, and an urgent need, to improve women's health more broadly. I support start-ups in femtech too. Even when their innovation is not directly related to molecular diagnostics, the challenge is often the same: turning great science into solutions that reach the women who need them.

Nice to know about me as well: outside work you will find me dancing, travelling, skiing, or spending time with my family and friends, cooking together or going to concerts.

Michelle Meijer working on her laptop

Why infacts?

In facts, and contagious

InFacts stands for working from evidence: in facts. You may recognise a double meaning here. And yes, that is intended: in my experience, knowledge and enthusiasm are contagious.

Just like in diagnostics, my work starts with the facts and leads to the best treatment plan: one we agree on together, and then carry out.

Evidence-based

Advice grounded in facts, data, proven and validated methodologies, and a real understanding of your science.

Results-driven

Agreed is agreed. Once we have aligned on the best plan, we stick to it, with the people, deadlines and resources in place and disciplined project management to deliver what we agreed.

Hands-on and practical

I work alongside your team, with an approach tailored to your situation. Advice and training you can apply the very next day.

Honest and direct

I tell you what I see, not what you would like to hear.

Career highlights

25+ years in molecular diagnostics

  1. 2018 – now
    Founder and senior life sciences consultant · InFacts
    Consultancy, interim leadership and commercial training.
  2. 2019 – 2025
    CCO and COO · Self-screen
    International commercialisation of molecular IVD assays for HPV-induced cancers.
  3. 2020 – 2021
    Vice President Sales · ENPICOM
    Built the commercial organisation for an immune repertoire sequencing platform.
  4. 2018 – 2019
    Sales and Marketing Director · OncoDNA
    NGS-based profiling and bioinformatics for precision medicine in oncology.
  5. 2008 – 2015
    Country Manager, Head of Sales Benelux · QIAGEN
    Life sciences and molecular diagnostics, through the Dutch move to primary HPV screening.
  6. 2005 – 2008
    Business Development Manager · Roche Diagnostics
    Introduced PCR-based diagnostics, including HPV DNA testing.
  7. 1998 – 2005
    Product Line Manager, MT member · Westburg
    From technical sales to commercial leadership, Benelux and Nordics.

Professional and societal engagement

Committed beyond assignments

  • HPV BridgeCo-founder and Steering Committee member of an international consortium developing consensus criteria for molecular triage in cervical cancer screening
  • Taskforce HPV-kankervrij ↗Member of the Dutch taskforce working towards a Netherlands free of HPV-related cancer
  • Diagned ↗Former board member (2014 – 2016) of the Dutch association of in vitro diagnostics suppliers, championing the value of diagnostics
  • Stichting Olijf ↗Volunteer at the Dutch patient organisation for women with gynaecological cancer

Let's make your science catch on.

I would love to hear what you are working on. I will get back to you within two working days.